Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NTRA
NATERA, INC.
NASDAQ
$326.26
▼ DOWN 3.67% (-12.44)

KEY STATISTICS

Market Cap$46.73 B
52w High$343.18
52w Low$157.43
Dividend Yield—
Frequency—
P/E-247.17
Volume833.44K
Shares Out.143.22M

COMPANY

LEADERSHIP

Steven Leonard Chapman
CHIEF EXECUTIVE
Steven Leonard Chapman

COMPENSATION 2026

Salary$853,710
Stock Awards$12,979,558
Incentive Plan Pay$1,114,151
All Other Comp.$9,900
Total$14,957,319

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 1, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6,138

PRICE TARGET

Target High$375.00
Target Low$245.00
Target Median$335.00
Target Consensus$319.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$706.87M
NOV
5
THU

PRICE

$326.26 ▼ DOWN 3.67% (−$12.44)
$328$332$336$3409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM326.26

About Natera, Inc.

https://www.natera.com ↗

Natera, Inc. is a global diagnostics company offering molecular testing services—including prenatal, genetic, miscarriage, paternity, cancer, and transplant tests—via innovative assays, cloud software, and partnerships since 2003.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT NATERA, INC. IS KNOWN FOR

Fetal Focus™
Fetal Focus™

Fetal Focus™ is a non-invasive prenatal test analyzing maternal blood to screen for 21 inherited single-gene conditions, launched in 2025 and expanded in 2026, addressing prenatal care gaps when the father is unavailable.

COMPETITORS

COMPETITOR
DGX COMPARE
GH COMPARE
LH COMPARE
MYGN COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$590.2M $661.16M ▲$693.87M ▲$747.93M ▲
Licensing and other$1.99M $4.34M ▲— —
Oncology— — $100K $300K ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$582.37M $651.79M ▲$685.6M ▲$739.47M ▲
EMEA— — $6.42M $9.02M ▲
Europe Middle East India Africa$6.01M — — —
Americas Excluding US$1.52M $4.57M ▲— —
Americas Excluding United States— — $2.4M $2.22M ▼
Asia Pacific And Other$2.28M $2.13M ▼$2.22M ▲$2.05M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
534
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.05% · 4.3M
IBB
3.16% · 1.0M
LYYA.DE
1.64% · 610.3K
XBI
1.39% · 489.7K
JGRO
1.38% · 408.6K
SCHG
0.19% · 347.7K
FBT
3.80% · 335.4K
ARKG
4.05% · 255.3K
GSLC
0.39% · 176.6K
CNEQ
1.85% · 136.5K
DBXU.DE
0.32% · 89.5K
QQQJ
2.34% · 83.3K
BBH
5.15% · 73.2K
H4ZJ.SG
0.12% · 70.8K
CGMM
0.58% · 64.7K
FHLC
0.62% · 64.6K
TGED.TO
1.49% · 57.4K
XO
XOVR
0.02% · 50.2K
JHMM
0.24% · 44.2K
TGRT
0.93% · 43.7K
DFAC
0.03% · 42.9K
QMOM
2.55% · 32.9K
PB
PBPH
1.00% · 30.8K
WRDUSW.SW
0.05% · 26.2K
GR
GRNJ
1.62% · 25.3K
XMLH.DE
2.50% · 24.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
57.78%
HOLDERS
1,069
TOP 12 OF 1,069 · RANKED BY POSITION SIZE
Jpmorgan Chase & Co
13.4M sh · $2.5B
Vanguard Group Inc
12.4M sh · $1.99B
Price T Rowe Associates Inc /Md/
12.2M sh · $2.44B
Blackrock, Inc.
11.0M sh · $1.76B
Blackrock Inc.
6.8M sh · $733.28M
Fmr LLC
5.5M sh · $1.48B
Wellington Management Group Llp
5.0M sh · $1.14B
Farallon Capital Management LLC
4.3M sh · $684.68M
State Street Corp
3.7M sh · $992.32M
Duquesne Family Office LLC
3.2M sh · $517.44M
Geode Capital Management, LLC
2.8M sh · $553.82M
Franklin Resources Inc
2.7M sh · $739.95M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Purchase
2025-09-22
 Daniel Goldman
Daniel Goldman
Sale
2023-04-10
SENATE TRADES
Bill Hagerty
Bill Hagerty
Sale (Partial)
2021-04-20

INSIDER TRADES

★
OFFICER: PRESIDENT, CHIEF BUS. OFFICER
Fesko John
Purchase · 20.0K shares
2026-08-06
★
OFFICER: PRESIDENT, CHIEF BUS. OFFICER
Fesko John
Sale · 6.5K shares
2026-08-10
★
DIRECTOR, OTHER: CO-FOUNDER
Sheena Jonathan
Sale · 6.0K shares
2026-08-10
★
DIRECTOR, OTHER: CO-FOUNDER
Sheena Jonathan
Sale · 5.1K shares
2026-08-07

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OVERWEIGHT 5
OUTPERFORM 3
EQUAL WEIGHT 1
NEUTRAL 1
16 GRADES IN THE LAST 12 MONTHS
Citigroup BUY Guggenheim BUY Piper Sandler OVERWEIGHT Stephens & Co. OVERWEIGHT Wells Fargo EQUAL WEIGHT BTIG BUY Evercore ISI Group OUTPERFORM JP Morgan OVERWEIGHT

SECTORS PEERS

PEERPRICE
IQV$261.75COMPARE
TEVA$36.44COMPARE
DXCM$90.82COMPARE
ILMN$215.59COMPARE
WAT$414.69COMPARE
MTD$1398.58COMPARE
DGX$242.76COMPARE
PHG$26.72COMPARE